Atlas Trials

SkinJect, Inc.

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch SkinJect, Inc.

RecordFirmDate
Phase 2 Study Evaluating the Safety and Efficacy of Microneedle-mediated Delivery of Doxorubicin (D-MNA) in Patients With Nodular Basal Cell Carcinoma. (NCT06608238)SkinJect, Inc.2024-09-03
Placebo Microneedles in Healthy Volunteers (Part I) and Efficacy/Safety of Doxorubicin Microneedles in Basal Cell Cancer Subjects (Part II) (NCT04928222)SkinJect, Inc.2021-09-24
Dose Escalation Trial to Evaluate Dose Limiting Toxicity/Maximum Tolerated Dose of Microneedle Arrays Containing Doxorubicin (D-MNA) in Basal Cell Carcinoma (BCC) (NCT03646188)SkinJect, Inc.2020-06-10

Track SkinJect, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.